|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-3-22
|
|
pubmed:abstractText |
Botulinum toxin type A is a potent neuromuscular paralyzing agent used in various disorders including cervical dystonia. Two preparations of botulinum toxin are now commercially available ( Dysport and Botox), but much controversy remains about their respective potencies. The aim of the study was to compare the efficacy of Botox with two different ratios of Dysport.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-11909897,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-12397170,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-1624292,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-2011163,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-2642616,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-2874278,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-7608697,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-7968058,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-8078064,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-8990059,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-8990061,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-9089663,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-9399229,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-9436720,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-9436721,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11909903-9686787
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-3050
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
459-62
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11909903-Adult,
pubmed-meshheading:11909903-Aged,
pubmed-meshheading:11909903-Botulinum Toxins, Type A,
pubmed-meshheading:11909903-Cross-Over Studies,
pubmed-meshheading:11909903-Dose-Response Relationship, Drug,
pubmed-meshheading:11909903-Double-Blind Method,
pubmed-meshheading:11909903-Female,
pubmed-meshheading:11909903-Humans,
pubmed-meshheading:11909903-Male,
pubmed-meshheading:11909903-Middle Aged,
pubmed-meshheading:11909903-Neuromuscular Agents,
pubmed-meshheading:11909903-Pain,
pubmed-meshheading:11909903-Therapeutic Equivalency,
pubmed-meshheading:11909903-Torticollis
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.
|
|
pubmed:affiliation |
Service de Neurologie, Hôf.pital Sainte-Anne, Paris, France. ranoux@chsa.broca.inserm.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
